BTAI
Price
$1.72
Change
-$0.01 (-0.58%)
Updated
Jun 20, 11:27 AM (EDT)
Capitalization
10.48M
LEXX
Price
$0.95
Change
-$0.05 (-5.00%)
Updated
Jun 20, 11:38 AM (EDT)
Capitalization
19.56M
28 days until earnings call
Interact to see
Advertisement

BTAI vs LEXX

Header iconBTAI vs LEXX Comparison
Open Charts BTAI vs LEXXBanner chart's image
BioXcel Therapeutics
Price$1.72
Change-$0.01 (-0.58%)
Volume$700
Capitalization10.48M
Lexaria Bioscience
Price$0.95
Change-$0.05 (-5.00%)
Volume$2K
Capitalization19.56M
BTAI vs LEXX Comparison Chart in %
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. LEXX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and LEXX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (BTAI: $1.73 vs. LEXX: $1.00)
Brand notoriety: BTAI and LEXX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 42% vs. LEXX: 50%
Market capitalization -- BTAI: $10.48M vs. LEXX: $19.56M
BTAI [@Biotechnology] is valued at $10.48M. LEXX’s [@Biotechnology] market capitalization is $19.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileLEXX’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • LEXX’s FA Score: 0 green, 5 red.
According to our system of comparison, LEXX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 5 TA indicator(s) are bullish while LEXX’s TA Score has 4 bullish TA indicator(s).

  • BTAI’s TA Score: 5 bullish, 5 bearish.
  • LEXX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LEXX is a better buy in the short-term than BTAI.

Price Growth

BTAI (@Biotechnology) experienced а -3.35% price change this week, while LEXX (@Biotechnology) price change was -3.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

LEXX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEXX($19.6M) has a higher market cap than BTAI($10.5M). LEXX YTD gains are higher at: -52.381 vs. BTAI (-71.082). LEXX has higher annual earnings (EBITDA): -9.32M vs. BTAI (-24.24M). BTAI has more cash in the bank: 31M vs. LEXX (6.54M). LEXX has less debt than BTAI: LEXX (124K) vs BTAI (106M). BTAI has higher revenues than LEXX: BTAI (1.85M) vs LEXX (526K).
BTAILEXXBTAI / LEXX
Capitalization10.5M19.6M54%
EBITDA-24.24M-9.32M260%
Gain YTD-71.082-52.381136%
P/E RatioN/AN/A-
Revenue1.85M526K352%
Total Cash31M6.54M474%
Total Debt106M124K85,484%
FUNDAMENTALS RATINGS
BTAI vs LEXX: Fundamental Ratings
BTAI
LEXX
OUTLOOK RATING
1..100
483
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6591
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LEXX's Valuation (41) in the null industry is somewhat better than the same rating for BTAI (81) in the Biotechnology industry. This means that LEXX’s stock grew somewhat faster than BTAI’s over the last 12 months.

LEXX's Profit vs Risk Rating (100) in the null industry is in the same range as BTAI (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

LEXX's SMR Rating (99) in the null industry is in the same range as BTAI (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

BTAI's Price Growth Rating (65) in the Biotechnology industry is in the same range as LEXX (91) in the null industry. This means that BTAI’s stock grew similarly to LEXX’s over the last 12 months.

BTAI's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LEXX (100) in the null industry. This means that BTAI’s stock grew similarly to LEXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAILEXX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMLR31.943.41
+11.95%
Semler Scientific
JOBY8.840.19
+2.20%
Joby Aviation
CYRX6.780.04
+0.59%
CryoPort
TECK38.24-0.25
-0.65%
Teck Resources Limited
CNVS3.98-0.03
-0.75%
Cineverse Corp

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with ORMP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
+5.49%
ORMP - BTAI
44%
Loosely correlated
-0.46%
AXON - BTAI
42%
Loosely correlated
-0.87%
INO - BTAI
39%
Loosely correlated
+2.63%
IGMS - BTAI
38%
Loosely correlated
-1.68%
ARRY - BTAI
37%
Loosely correlated
+1.48%
More

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and PDSB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
N/A
PDSB - LEXX
29%
Poorly correlated
-0.62%
MIST - LEXX
28%
Poorly correlated
-0.58%
STRO - LEXX
28%
Poorly correlated
+0.47%
BTAI - LEXX
27%
Poorly correlated
+5.49%
VERV - LEXX
27%
Poorly correlated
-2.28%
More